Marketing-authorisation holder · United States
GlaxoSmithKline Biologicals
32 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
32 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 32
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Arexvy120ug/.5ml · For Injection | Respiratory syncytial virus vaccine, adjuvanted | United States | Marketed | 2023 |
| Bexsero0.5ml · Injection | Meningococcal group b vaccine | United States | Marketed | 2015 |
| Boostrix2.5lf, 5lf, 2.5ug, 8ug ug/.5ml · Injection | Tetanus toxoid, reduced diphtheria toxoid, Acellular pertussis vaccine, adsorbed | United States | Marketed | 2005 |
| Boostrix2.5lf, 5lf, 2.5ug, 8ug ug/.5ml · Injection | Tetanus toxoid, reduced diphtheria toxoid, Acellular pertussis vaccine, adsorbed | United States | Marketed | 2005 |
| Cervarix0.5ml · Injection | Human papillomavirus bivalent (types, Vaccine, recombinant | United States | Not marketed | 2009 |
| Engerix-B10ug/.5ml · Injection | Hepatitis b vaccine | United States | Marketed | 1989 |
| Engerix-B10ug/.5ml · Injection | Hepatitis b vaccine | United States | Marketed | 1989 |
| Engerix-B20ug/ml · Injection | Hepatitis b vaccine | United States | Marketed | 1989 |
| Engerix-B20ug/ml · Injection | Hepatitis b vaccine | United States | Marketed | 1989 |
| Fluarix, Fluarix Quadrivalent45ug/.5ml · Injection | Influenza vaccine | United States | Marketed | 2005 |
| Fluarix, Fluarix Quadrivalent60ug/.5ml · Injection | Influenza vaccine | United States | Not marketed | 2012 |
| Havrix1440elisa u/ml · Injection | Hepatitis a vaccine | United States | Marketed | 1995 |
| Havrix1440elisa u/ml · Injection | Hepatitis a vaccine | United States | Marketed | 1995 |
| Havrix720elisa u/.5ml · Injection | Hepatitis a vaccine | United States | Marketed | 1995 |
| Havrix720elisa u/.5ml · Injection | Hepatitis a vaccine | United States | Marketed | 1995 |
| Hiberix10ug/25ug · For Injection | Haemophilus b conjugate vaccine | United States | Marketed | 2009 |
| Infanrix25lf/10lf/25ug/.5ml · Injection | Diphtheria tetanus toxoids acellular pertussis vaccine adsorbed | United States | Marketed | 1997 |
| Infanrix25lf/10lf/25ug/.5ml · Injection | Diphtheria tetanus toxoids acellular pertussis vaccine adsorbed | United States | Marketed | 1997 |
| Kinrix0.5ml · Injection | Diphtheria, Tetanus toxoids, Acellular pertussis adsorbed, Inactivated poliovirus vaccine | United States | Marketed | 2008 |
| Menveo0.5ml · Injection | Meningococcal (groups a, c, y, W-135) oligosaccharide diphtheria crm197 conjugate vaccine | United States | Marketed | 2022 |
| Menveo0.5ml · Injection | Meningococcal (groups a, c, y, W-135) oligosaccharide diphtheria crm197 conjugate vaccine | United States | Marketed | 2010 |
| Pediarix0.5ml · Injection | Diphtheria, Tetanus toxoids, Acellular pertussis adsorbed, hepatitis b, Inactivated poliovirus vaccine | United States | Marketed | 2002 |
| PENMENVY25ug/0.5ml · Injection | Meningococcal groups a, b, c, w, Y vaccine | United States | Marketed | 2025 |
| PRIORIX3.4, 4.2 and 3.3LOG10 · For Injection | Measles, mumps, Rubella vaccine live | United States | Marketed | 2022 |
| Rotarix106.0ccid50 · Suspension | Rotavirus vaccine, live, oral | United States | Marketed | 2022 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 32 | 31 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.